Obesity, hypertension, and cigarette smoking remain the leading potentially modifiable risk factors involved in the pathogenesis. Clear cell carcinoma is considered uniformly metastatic, irrespective of the tumor size. Lytic bony metastases, which might become sclerotic with treatment, can be present. Lung, bone, brain, liver, lymph nodes, liver, and adrenal glands form the main sites of dissemination.

Ĭlear cell tumors have the propensity to spread hematogenous, with direct extension into the major vessels – namely the renal veins and the inferior vena cava. The goals of the management of advanced RCC emphasize a focus upon improvement in the quality of life parameters. As is expected, diagnosis at an earlier stage offers a relatively higher chance of cure. The cancer-specific 10-year survival ranges from 71 percent in clear cell cancer to 91 percent in papillary cancer, 88 percent in chromophobe cancer, and 33 percent in collecting duct cancers. The percentage of distant metastases in these various subtypes varies from 15 percent in clear cell carcinoma to 3 percent in papillary and 4 percent in chromophobe cell cancers. Clear cell and papillary cell cancer originate from the proximal tubular cells, while chromophobe cell cancers originate from the intercalated cells. Traditional morphological classification of these tumors divides them into three main subtypes – clear cell, papillary, and chromophobe subtypes. Renal cell carcinoma, of which clear cell carcinoma is the most common histological subtype (80 to 90 percent), comprises 90 percent of all Kidney tumors. Review interprofessional team strategies for improving care coordination and communication to advance patient-related outcomes in clear cell renal carcinoma.Outline the options available in the management of clear cell renal cancer.Summarize the role of history taking, physical examination, radiological investigations in the evaluation and management of clear cell renal cancer.Review the histopathological findings of clear cell renal cancer.This activity describes the evaluation and management of this aggressive tumor, while also trying to highlight the role of the interprofessional team in the comprehensive management of the patient. It is known as the internist tumor and is well known to cause a wide spectrum of paraneoplastic manifestations to mimic other tumors and benign conditions. Clear cell renal cancer is the most common type of kidney cancer, comprising 80 percent of all malignant tumors found within the kidney.

Keynote 426 criticism